Hello, Old Friend: Where Have You Been? French Antitrust Agency Levies Eye-Watering $510 Million Fine on Three Pharmaceutical Firms and Breathes New Life into Collective Dominance

Published date01 October 2020
Subject MatterEU,Prescription Drugs,Antitrust Litigation,False Claims Act (FCA),Pharmaceutical Industry,European Medicines Agency (EMA)
AuthorPaul McGeown
Law FirmWilson Sonsini Goodrich & Rosati

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT